A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages

Early diagnosis of Alzheimer’s disease (AD) is a crucial starting point in disease management. Blood-based biomarkers could represent a considerable advantage in providing AD-risk information in primary care settings. Here, we report new data for a relatively unknown blood-based biomarker that holds...

Descripción completa

Detalles Bibliográficos
Autores principales: Abate, Giulia, Vezzoli, Marika, Polito, Letizia, Guaita, Antonio, Albani, Diego, Marizzoni, Moira, Garrafa, Emirena, Marengoni, Alessandra, Forloni, Gianluigi, Frisoni, Giovanni B., Cummings, Jeffrey L., Memo, Maurizio, Uberti, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823360/
https://www.ncbi.nlm.nih.gov/pubmed/33375220
http://dx.doi.org/10.3390/jpm11010014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823360/
https://www.ncbi.nlm.nih.gov/pubmed/33375220
http://dx.doi.org/10.3390/jpm11010014

Ejemplares similares